Morbidity and Mortality Weekly Report (MMWR)
COVID-19 Reports
- Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant — New York City, New York, January 1–April 5, 2021
- Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 — Colorado, January–March 2021
- Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios — United States, April–September 2021
Current Weekly
Also in this issue
Surveillance Summaries
March 19, 2021
Malaria Surveillance — United States, 2017
CDC received 2,161 reports of confirmed malaria cases among persons tested in the United States and its territories with onset of symptoms in 2017. This number continues a decades-long increasing trend.
Recommendations and Reports
May 7, 2021
Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021
Botulism is a rare, neurotoxin-mediated, life-threatening disease characterized by flaccid descending paralysis that begins with cranial nerve palsies and might progress to extremity weakness and respiratory failure. These evidence-based guidelines provide health care personnel with recommended best practices for diagnosing, monitoring, and treating botulism in the settings of conventional, contingency, and crisis standards of care.
Youth Risk Behavior Surveillance
August 21, 2020
Overview and Methods for the Youth Risk Behavior Surveillance System — United States, 2019
The Youth Risk Behavior Surveillance System monitors health behaviors, conditions, and experiences among high school students throughout the United States. Data can be used to identify student risk behaviors, monitor health behavior trends, guide public health interventions, and track progress toward national health objectives.
